Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Marina F. de Souza Cartaxo"'
Autor:
Sophia Maria D Silva, Fábio André Brayner, Albanita Gomes da Costa de Ceballos, José Luiz de Lima Filho, Eduardo Isidoro Carneiro Beltrão, Marina F. de Souza Cartaxo, Jaiurte Gomes Martins da Silva, Luiz Carlos Alves, Juliana Araújo de Carvalho Schettini, Sandra da Silva Mattos
Publikováno v:
Transactions of The Royal Society of Tropical Medicine and Hygiene. 113:65-73
Background Repellent use during pregnancy was strongly recommended after uncovering Zika virus (ZIKV) involvement with congenital malformations. In this context, Pernambuco, Brazil played a key role since it was the epicentre for the main studies sug
Autor:
Cássia R A, da Cunha, Luís C N, da Silva, Fábio J F, Almeida, Milena S, Ferraz, Nathalia, Varejão, Marina F de Souza, Cartaxo, Rita de Cássia M, de Miranda, Francisco C A, de Aguiar, Noemia P da Silva, Santos, Luana C B B, Coelho, Nereide S, Santos-Magalhães, Maria T Dos Santos, Correia
Publikováno v:
Frontiers in Microbiology
This study evaluated the in vivo antitumor potential of the recombinant lectin from seeds of Cratylia mollis (rCramoll) expressed in Escherichia coli, free or encapsulated in stealth liposomes, using mice transplanted with sarcoma 180. rCramoll-loade
Autor:
Maria Bm Oliveira, Eduardo Ic Beltrão, Carmelita C. B. Cavalcanti, Eduardo Avf Ramalho, Marina F. de Souza Cartaxo, João Lq Silva-Filho, Moacyr J. B. M. Rêgo
Publikováno v:
Biological Research
Biological Research v.47 2014
SciELO Chile
CONICYT Chile
instacron:CONICYT
Biological Research, Volume: 47, Pages: 1-7, Published: 2014
Biological Research, Vol 47, Iss 0, Pp 1-7 (2014)
Biological Research v.47 2014
SciELO Chile
CONICYT Chile
instacron:CONICYT
Biological Research, Volume: 47, Pages: 1-7, Published: 2014
Biological Research, Vol 47, Iss 0, Pp 1-7 (2014)
Background BRCA protein interacts with at least 13 different proteins that have been implicated with cancer susceptibility and loss of BRCA function is correlated to sensitivity to DNA crosslinking agents in preclinical models. Results BRCA2 methylat